Company Profile
Evaxion Biotech Stock Price, News & Analysis
- Ticker:
- EVAX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Denmark
Stock performance
3.00 USD (+0.50%)
Close
Last updated: August 6, 2026
31.3M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, EVAX closed up 0.50% at $3.00. No new same-company headline was identified in the current news window.
Company overview
Business overview
Evaxion Biotech is a biotechnology company focused on AI-enabled vaccine and immunotherapy discovery. Its platform aims to combine computational methods with immune science to create new therapies.
Geographic Base and Sector Classification
Headquartered in Denmark and listed on NASDAQ as an ADR, Evaxion has a global AI-biotech profile.
Business Model Characteristics
The company depends on platform adoption, clinical validation, and the ability to convert AI-assisted discovery into pipeline value.
Position Within the Biotechnology Landscape
Evaxion is a hybrid AI-biotech name whose valuation depends on both platform credibility and drug progress.
Future catalysts
Evaxion’s catalysts are AI-designed vaccine programs and any clinical or partnership update that shows the platform can turn computational design into human value. The next step matters because the company still needs real proof.
Recent news
- 01
Important Milestone Reached for Evaxion Biotech’s EVX-01 Personalized Cancer Therapy
Source: Evaxion Biotech
- 02
Evaxion Announces NIH Grant for Research Collaboration With UMass Chan Medical School
Source: Evaxion Biotech
- 03
Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update
Source: Evaxion Biotech
- 04
Evaxion Biotech A/S Announces Executive Management Changes
Source: Evaxion Biotech
- 05
Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10
Source: Evaxion Biotech
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Evaxion Biotech (EVAX)?
Evaxion Biotech (EVAX) most recently closed at 3.00 USD, a +0.50% move versus the previous session.
What is the market cap of Evaxion Biotech (EVAX)?
Evaxion Biotech currently has a market capitalization of 31.3M USD on BioPharmSignal.
What does Evaxion Biotech do?
Evaxion Biotech is a biotechnology company focused on AI-enabled vaccine and immunotherapy discovery. Its platform aims to combine computational methods with immune science to create new therapies.
On which exchange is EVAX stock listed?
Evaxion Biotech (EVAX) is associated with NASDAQ, Denmark, Biopharma.
What is Evaxion?
Evaxion’s catalysts are AI-designed vaccine programs and any clinical or partnership update that shows the platform can turn computational design into human value.
Which conditions is Evaxion Biotech targeting with Evaxion?
Evaxion’s catalysts are AI-designed vaccine programs and any clinical or partnership update that shows the platform can turn computational design into human value.
How does Evaxion Biotech describe recent progress with Evaxion?
Evaxion’s catalysts are AI-designed vaccine programs and any clinical or partnership update that shows the platform can turn computational design into human value.
What is Biotech?
Evaxion Biotech is a biotechnology company focused on AI-enabled vaccine and immunotherapy discovery.